The OPTIMIZE project is dedicated to rapidly improving treatment outcomes for people living with HIV by optimizing antiretroviral drugs and formulations, and accelerating their introduction in low- and middle-income countries, including Zimbabwe. (funded by USAID)

Find out more at optimize.icap.columbia.edu

The HIV Coverage, Quality, and Impact Network (CQUIN) is a multi-country learning network designed to accelerate the implementation of high-quality differentiated care for HIV in member countries across sub-Saharan Africa, including Zimbabwe. Through CQUIN, ICAP supports countries to generate new knowledge and tools to advance differentiated care, and facilitates learning about the science of scale-up. In Zimbabwe, CQUIN supports a Differentiated Care Coordinator, who is seconded to the Ministry of Health; a study assessing barriers and facilitators of men’s engagement in HIV treatment and differentiated care; and work to identify differentiated care models for patients with advanced or unstable HIV. (funded by Bill & Melinda Gates Foundation)

Find out more at cquin.icap.columbia.edu

ICAP is conducting a discrete choice experiment to evaluate preferences for differentiated service delivery models among people living with HIV in urban Zimbabwe.

Optimizing Momentum Toward Sustainable Epidemic Control (OpCon) is a global initiative led by ICAP at Columbia University and funded by PEPFAR through HRSA.

OpCon can assist countries in addressing the challenges they face in reaching epidemic control, sustaining achievements, and exploring innovations to measure progress.

ICAP provided technical assistance to the Ministry of Health and Child Care (MOHCC) to conduct the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) survey, which assessed HIV prevalence, incidence, and access to HIV prevention, care, and treatment services. The survey comprised household-based interviews and HIV counseling and testing services for adults and children. Conducted between October 2015 and August 2016, the survey found that HIV incidence, 0.45 percent (ages 15 to 64), is lower than previously estimated. Compared to the 2003 incidence estimates between 1.3 and 1.5 percent per year, the current rate of new HIV infections has been cut in half during the past 13 years, when effective HIV treatment became available in sub-Saharan Africa, largely through support from PEPFAR.

Find out more at phia.icap.columbia.edu

ICAP is providing technical assistance to strengthen epidemiology and strategic information (SI) to inform evidence-based HIV programs and policy. Activities aim to support the MOHCC to plan and coordinate SI activities, improve monitoring and evaluation, and enhance surveillance systems to characterize the HIV epidemic and effectiveness of the response. The scope of work also includes strengthening human resources to support country ownership of sustainable SI activities. (funded by PEPFAR through the CDC)